Dr.Neal’s research interests include the environmental determinants of chronic disease and the potential for changes in the food supply to deliver large, cost-effective and equitable health gains. He was a founding member and currently serves as Executive Director, The George Institute for Global Health. He also serves as Professor of Medicine, UNSW Sydney, and Professor of Clinical Epidemiology at Imperial College London. He has expertise in the management of high blood pressure and diabetes and has played lead roles in multiple large-scale clinical trials. His work has been characterized by its focus on collaboration, quantitation, translation and impact.
Dr. Neal holds additional professorial appointments at Flinders University in South Australia, an honorary appointment at the University of Sydney and chairs the Australian Division of World Action on Salt and Health. He was identified by Thomson Reuters as one of ‘The World’s Most Influential Scientific Minds’, an acknowledgement provided to just 3000 researchers across all disciplines, worldwide. He has particular expertise in salt reduction but also a broader knowledge of food policy issues related to sugars, fats, portion size and food labelling. Dr. Neal has played lead roles in multiple large-scale clinical trials, most recently of SGLT2 inhibition.